Strategic Partnerships Synonym is expanding via strategic integrations and collaborations, notably the Brenntag partnership announced in late 2025 to extend global reach and formulation capabilities. This indicates a clear channel for joint offerings and co-sell opportunities with large distribution and customer networks.

Biomanufacturing Platform As a leading integrated production platform for bioproducts with a focus on data services and capacity-partner production, Synonym offers a compelling value proposition for customers seeking scalable biomanufacturing infrastructure, potentially appealing to mid-sized biotechs and established players looking to de-risk scale-up.

Cost Modeling Tool The launch of Scaler, a free online tool to project costs of production and operations at commercial scale, creates a recurring engagement channel. This can be leveraged for upsell into premium analytics, optimization services, and longer-term advisory engagements for companies planning scale-up.

Advisory and Legal Talent Recent addition of senior Counsel positions signals a strong emphasis on regulatory, IP, and compliance matters—an avenue to offer targeted services or bundles for clients navigating biomanufacturing approvals, supply chain governance, and product liability considerations.

Capital-Efficient Growth With pre-seed funding rounds and a lean team size, Synonym demonstrates capital efficiency and rapid go-to-market capability. This presents opportunities to target early-stage biotech startups and scale-up companies with affordable, outcome-driven collaboration models and phased pilot programs.